Home

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revision Previous revision
home:diseases:diabetes2 [03.21.2019]
sallieq [Recent Research]
home:diseases:diabetes2 [07.10.2019] (current)
sallieq [Research]
Line 31: Line 31:
  
 This trial aims to determine the effects of resistant starch (RS) subtype 2 (RS2) on glycemic status, metabolic endotoxemia and markers of oxidative stress. ​ (({{pubmed>​long: ​   26655398}})) This trial aims to determine the effects of resistant starch (RS) subtype 2 (RS2) on glycemic status, metabolic endotoxemia and markers of oxidative stress. ​ (({{pubmed>​long: ​   26655398}}))
 +
 +Among persons at high risk for type 2 diabetes not selected for vitamin D insufficiency,​ vitamin D3 supplementation at a dose of 4000 IU per day did not result in a significantly lower risk of diabetes than placebo. (({{pubmed>​long:​31173679}}))
  
  
home/diseases/diabetes2.txt · Last modified: 07.10.2019 by sallieq
© 2015, Autoimmunity Research Foundation. All Rights Reserved.